<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Investig Clin Urol</journal-id><journal-id journal-id-type="iso-abbrev">Investig Clin Urol</journal-id><journal-id journal-id-type="publisher-id">ICU</journal-id><journal-title-group><journal-title>Investigative and Clinical Urology</journal-title></journal-title-group><issn pub-type="ppub">2466-0493</issn><issn pub-type="epub">2466-054X</issn><publisher><publisher-name>The Korean Urological Association</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28480343</article-id><article-id pub-id-type="pmc">5419106</article-id><article-id pub-id-type="doi">10.4111/icu.2017.58.3.179</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject><subj-group subj-group-type="subheading"><subject>Endourology/Urolithiasis</subject></subj-group></subj-group></article-categories><title-group><article-title>Evaluation of the effect of Bernoulli maneuver on operative time during mini-percutaneous nephrolithotomy: A prospective randomized study</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Gadzhiev</surname><given-names>Nariman</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Sergei</surname><given-names>Brovkin</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Grigoryev</surname><given-names>Vladislav</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Okhunov</surname><given-names>Zhamshid</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Ganpule</surname><given-names>Arvind</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Pisarev</surname><given-names>Aleksei</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Iskakov</surname><given-names>Yerbol</given-names></name><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author"><name><surname>Petrov</surname><given-names>Sergei</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib></contrib-group><aff id="A1"><label>1</label>The Federal State Institute of Public Health &#x02018;The Nikiforov Russian Center of Emergency and Radiation Medicine&#x02019;, Saint-Petersburg, Russia.</aff><aff id="A2"><label>2</label>Department of Urology, University of California, Irvine, CA, USA.</aff><aff id="A3"><label>3</label>Muljibhai Patel Urological Hospital, Nadiad, India.</aff><aff id="A4"><label>4</label>The Saint-Petersburg State University clinic, Saint-Petersburg, Russia.</aff><aff id="A5"><label>5</label>Second City Hospital, Astana, Kazakhstan.</aff><author-notes><corresp>
Corresponding Author: Nariman Gadzhiev. The Federal State Institute of Public Health &#x02018;The Nikiforov Russian Center of Emergency and Radiation Medicine&#x02019;, Optikov 38, k1, Fl. 35. Saint Petersburg, Russia. TEL: +7-9214311436, FAX: +7-8126482408, <email>nariman.gadjiev@gmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><month>5</month><year>2017</year></pub-date><pub-date pub-type="epub"><day>03</day><month>4</month><year>2017</year></pub-date><volume>58</volume><issue>3</issue><fpage>179</fpage><lpage>185</lpage><history><date date-type="received"><day>28</day><month>11</month><year>2016</year></date><date date-type="accepted"><day>10</day><month>1</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; The Korean Urological Association, 2017</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0">http://creativecommons.org/licenses/by-nc/4.0</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Purpose</title><p>To evaluate the effect of &#x02018;Bernoulli maneuver&#x02019; (bringing the access sheath to horizontal plane) on operative time and stone free rates in patients undergoing mini-percutaneous nephrolithotomy (PCNL).</p></sec><sec><title>Materials and Methods</title><p>All consecutive patients with a solitary kidney stone undergoing a mini-PCNL between 2015 and 2016 were included into this study. Patients were randomized either to standard prone or control (C) group patients or to tilted prone with &#x02018;Bernoulli maneuver&#x02019; group (B) patients. Pre-, intra-, and postoperative characteristics of these 2 groups were recorded and analyzed.</p></sec><sec><title>Results</title><p>A total of 67 patients were included in the study. Of these, 40 patients were randomized to group C and 27 to group B. The mean (95% confidence limits) stone size (mm) in group C and B was 14 (13, 15) and 13 (11, 14), respectively (p=0.26). Nephroscopy time was shorter in Bernoulli group (35 minutes vs. 23 minutes, p=1.5&#x000b7;10<sup>-5</sup>, and Bayes factor <italic>BF</italic><sub>10</sub>=2,340, and Cohen standardized effect size <italic>d</italic><sub>st</sub>=1.2). The difference made it up 12 minutes (with 95% confidence interval from 8 to 18 minutes). There were no statistically significant differences between groups regarding white blood cell, creatinine level and stone-free status defined by computed tomography on the first postoperative day.</p></sec><sec><title>Conclusions</title><p>In our study the &#x02018;Bernoulli maneuver&#x02019; led to a shorter nephroscopy time in mini-PCNL. This maneuver can significantly reduce nephroscopy time and save significant amount of operative time, especially in tertiary referral centers with high-volume mini-PCNL procedures.</p></sec></abstract><kwd-group><kwd>Bernoulli</kwd><kwd>Nephrolithiasis</kwd><kwd>Percutaneous nephrolithotomy</kwd><kwd>Renal stone</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>Since the first introduction of percutaneous nephrolithotomy (PCNL) in 1976 [<xref rid="B1" ref-type="bibr">1</xref>] it has become the gold standard surgical treatment for large kidney stones. In order to reduce the morbidity associated with PCNL, several attempts have been made to modify the standard technique and reduce the size of instrumentation used for PCNL. The first significant size reduction has been proposed by Helal et al. [<xref rid="B2" ref-type="bibr">2</xref>] in 1997, who described the &#x02018;mini-PCNL&#x02019; technique in a 2-year-old child using 15 Fr. Hickman peel away introduction set. Further advances led to the development of metallic Amplatz sheath with nephroscope, where one of the prominent advantages was vacuum cleaner effect, consistent with hydrodynamic Bernoulli's principle [<xref rid="B3" ref-type="bibr">3</xref>]. According to this principle, during mini-PCNL, the front of a low pressure called &#x02018;pseudocavity&#x02019; is produced at the tip of nephroscope, which can extract the stone fragments through an access sheath without any additional grasping devices [<xref rid="B4" ref-type="bibr">4</xref>]. At a closer look, we have noticed that the horizontal plane, being one of the necessary conditions for Bernoulli equation, possibly for negation of gravitational influence on the flow velocity [<xref rid="B5" ref-type="bibr">5</xref>], was for some reason neglected.</p><p>In this study, we evaluated whether bringing the access sheath during mini-PCNL to the horizontal plane, which we called &#x02018;Bernoulli maneuver,&#x02019; by table manipulation and/or gentle hand assistance, can be beneficial regarding nephroscopy time. We compared the 2 groups of patients operated either in a standard prone or tilted prone position.</p></sec><sec sec-type="materials|methods"><title>MATERIALS AND METHODS</title><sec><title>1. Study design</title><p>We obtained Institutional Review Board approval to perform a single center prospective, randomized and controlled study (approval number: &#x00413;&#x0041d;&#x0041a; - 72345). All patients undergoing mini-PCNL procedure between February 2015 and April 2016 for solitary medium-sized kidney stones (1&#x02013;2 cm) of high density (more than 1,000 HU) were consented to be included in the study. Choice of treatment modality was dictated by existing guidelines [<xref rid="B6" ref-type="bibr">6</xref>] and local insurance coverage protocols. Randomization was performed via a web-based generator of true random numbers, in which the randomness comes from atmospheric noise (<ext-link ext-link-type="uri" xlink:href="http://www.random.org">www.random.org</ext-link>) and results were assigned to the control (C) and Bernoulli (B) groups in numbered envelopes. Patients with multiple or complex renal stones, stones in anomalous kidneys as well as patients with active infection or coagulation disorders were excluded from the study. Patient demographics and stone characteristics are shown in <xref ref-type="table" rid="T1">Table 1</xref>.</p><p>All PCNL procedures were performed by 2 competent surgeons [<xref rid="B7" ref-type="bibr">7</xref>] under general anesthesia. With the patient in the lithotomy position, a ureteral catheter 6 Fr was placed into the stone-bearing kidney under cystoscopic guidance. Then the patient was turned to the prone position and strapped down at the upper body and buttocks to the operating table (Alphamax, Maquet, Germany) to prevent sliding during &#x02018;Bernoulli maneuver&#x02019; (<xref ref-type="fig" rid="F1">Fig. 1</xref>).</p></sec><sec><title>2. Surgical technique</title><p>Our surgical technique has been described elsewhere [<xref rid="B8" ref-type="bibr">8</xref>]. Briefly, we routinely obtain percutaneous renal access under combined fluoroscopic and/or ultrasonic guidance. After calyceal puncture, a 0.035 hydrophilic guidewire (Roadrunner, Cook Medical, Bloomington, IN, USA) is inserted into the pelvicalyceal system (PCS). A &#x02018;single-step&#x02019; tract dilation, with a 16.5/19.5 Fr metal access sheath, is performed (Karl Storz, Tuttlingen, Germany). A rigid nephroscopy is conducted with a rigid 12-Fr nephroscope (Karl Storz). After identification of the stone, according to the group assignment, the patient was operated in either standard prone (<xref ref-type="fig" rid="F2">Fig. 2A</xref>) or tilted prone position (<xref ref-type="fig" rid="F2">Fig. 2B</xref>), with the maximum intention to bring access sheath to horizontal. Gentle hand assistance was applied to maximize tilting if needed (<xref ref-type="fig" rid="F2">Fig. 2C</xref>). Fragmentation of the stone mass instead of &#x0201c;laser painting&#x0201d; with the formation of fitting the access sheath particles, which were immediately evacuated via Bernoulli effect, was accomplished with laser lithotripter (VersaPulse 100 W, Lumenis, Israel) and 365 micron laser fiber, under the following initial parameters: 0.5 J and 20 Hz. Nor basket neither grasping device was needed during all operations. Nephrostomy/stent or totally tubeless ending was at the surgeons' discretion. Blood cell count and creatinine level were analyzed on the first postoperative day. Evaluated parameters in the study were nephroscopy time i.e., time from stone identification till the end of the evacuation of the last fragment, stone free and complication rates.</p></sec><sec><title>3. Definition of stone free status and follow-up imaging</title><p>Low-dose computed tomography (CT) imaging was obtained on all patients on postoperative day 1 to evaluate residual stones. Data acquisition was performed using a 64-row CT unit Somatom Definition AS (Siemens, Berlin, Germany). Stone free rate was defined as residual stones less than &#x0003c;2 mm [<xref rid="B9" ref-type="bibr">9</xref>].</p></sec><sec><title>4. Statistical analysis</title><p>Our approach to the statistical data analysis could be named &#x0201c;harmonizing statistical evidences and predictions.&#x0201d; It is rather fruitful because it combines not only confidence interval estimates for parameters, for the standardized effect size <italic>d</italic><sub>C</sub>, for the achieved power (1&#x02013;&#x003b2;), and planned sample sizes, but prediction intervals for them and for p-values, as well as estimates of posterior probabilities for the null hypothesis <italic>P</italic>(<italic>H</italic><sub>0</sub>&#x02502;D) and Bayes factors <italic>BF</italic><sub>10</sub>. For parameter estimation and hypothesis testing the complementary combination of frequentist (orthodox) and Bayesian approaches was used. Nonparametric bootstrapping and permutation (Monte Carlo) procedures were realized with the number of replicates and/or random permutations as large as possible (but no less than 1 million). For measurable variables (stone size and density) medians and their 95% confidence limits were calculated. Software PAST [<xref rid="B10" ref-type="bibr">10</xref>], BoxPlotR (<ext-link ext-link-type="uri" xlink:href="http://boxplot.tyerslab.com/">http://boxplot.tyerslab.com/</ext-link>), JASP (<ext-link ext-link-type="uri" xlink:href="https://jasp-stats.org/">https://jasp-stats.org/</ext-link>), G<sup>*</sup>Power [<xref rid="B11" ref-type="bibr">11</xref>] and LePrep (<ext-link ext-link-type="uri" xlink:href="http://lmrs.univ-rouen.fr/Persopage/Lecoutre/PAC.htm">http://lmrs.univ-rouen.fr/Persopage/Lecoutre/PAC.htm</ext-link>) have been involved.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>Total of 67 patients were included in the study; of these, 40 patients were randomized to group C and 27 patients to group B. Their ratio 1.5 with 95% confidence limits from 0.9 to 2.4 did not differ statistically from the expected 1:1 (p=0.14). Data in group C appeared not agree with a normal distribution (<xref ref-type="table" rid="T1">Table 1</xref>). So all statistical estimations and tests used were nonparametric. In group B the nephroscopy time was significantly shorter than in group C (<xref ref-type="fig" rid="F3">Fig. 3</xref>).</p><p>The time difference between studying groups was 12.6 minutes (with 95% confidence interval from 8 to 18 minutes). Bayes factor <italic>BF</italic><sub>10</sub>=2,340 means that the probability to receive the observed effect under the alternative hypothesis is 2,340 times larger than under the null hypothesis. At the same time, it means that the posterior odds in favor of the alternative hypothesis against the null hypothesis are 2,340 times larger then prior odds. This result agrees well with the high value of achieved power (<italic>Pow</italic>=0.998) and with a high probability of replication psrep=0.97. Prediction analysis shows that in replication the Cohen effect size <italic>d</italic><sub>st</sub> will be not less than 0.49 and p-value will not exceed 0.027 with the probability 95% (<xref ref-type="table" rid="T2">Table 2</xref>).</p><p>Moderate positive correlation was observed between stone size and nephroscopy time, where linear Pearson correlation coefficient appeared to be r=0.53 (4.5&#x000b7;10<sup>-6</sup>) and Spearman correlation coefficient was r<sub>s</sub>=0.55 (1.4&#x000b7;10<sup>-6</sup>) (<xref ref-type="fig" rid="F4">Fig. 4A</xref>) as well as between nephroscopy time and haemoglobin drop (<xref ref-type="fig" rid="F4">Fig. 4B</xref>), r=0.66 (1.5&#x000b7;10<sup>-9</sup>) and r<sub>s</sub>=0.55 (5&#x000b7;10<sup>-11</sup>).</p><p>No intraoperative complications such as profuse bleeding, PCS rupture etc. have occurred in the study. There were no statistically significant differences between groups in terms white blood cell count, creatinine level and stone-free status defined by CT on the first postoperative day. Though we did find statistically significant difference in hemoglobin (Hb) drop between groups (less in group B), it was not clinically significant (<xref ref-type="table" rid="T3">Table 3</xref>).</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>PCNL is a challenging procedure with a steep learning curve. There are many factors that have been shown to impact the surgical outcomes of PCNL procedures. These variables include surgeon's experience, patient and stone characteristics. Due to the challenging nature of the procedure, there have been many modifications suggested to improve patient related outcomes and stone free rates.</p><p>In this study we evaluated a simple yet reproducible maneuver to improve stone free rates and nephroscopy time. The &#x02018;Bernoulli maneuver,&#x02019; to our best knowledge, has never been evaluated before during PCNL procedures and this is the first study to quantitatively demonstrate the benefits of this simple technique. Our results demonstrated a shorter nephroscopy time in the &#x02018;Bernoulli&#x02019; group. On average, we saved 12 minutes just on nephroscopy time when the &#x02018;Bernoulli maneuver&#x02019; was used. Although this difference seems small and not very clinically significant, cumulatively makes a huge difference at tertiary centers such as our institution where we daily perform a high volume of surgical procedures for urolithiasis. Since this maneuver requires tilting the table, one should pay close attention for patient positioning and securing with tapes on the table to prevent slipping during the procedure. If the table tilting is not enough to bring access sheath to the horizontal plane then gentle hand assistance may be used, but not zealously &#x02013; not to tear the kidney.</p><p>Although we did not assess surgeons' subjective opinion, we believe that the maneuver makes the stone fragmentation and removal significantly easy. Possible explanation for the observed pattern may be reduced gravitational influence with the implementation of the &#x02018;Bernoulli maneuver.&#x02019; Moreover, one can observe a comparative easiness of fragments washout during standard PCNL in the supine position [<xref rid="B12" ref-type="bibr">12</xref>], though this effect does not occur so prominently in standard PCNL as compared to mini-PCNL [<xref rid="B13" ref-type="bibr">13</xref>].</p><p>Our study demonstrated positive correlations between the stone size and operative time, nephroscopy time and decrease in Hb level. These findings are consistent with the previous studies [<xref rid="B14" ref-type="bibr">14</xref><xref rid="B15" ref-type="bibr">15</xref>].</p><p>Today definition of mini-PCNL comprises utilization of access sheaths of size 14&#x02013;20 Fr [<xref rid="B15" ref-type="bibr">15</xref><xref rid="B16" ref-type="bibr">16</xref>]. According to this definition the first mention of &#x02018;mini PCNL&#x02019; was made by Helal et al. [<xref rid="B17" ref-type="bibr">17</xref>] in 1997 using 15 Fr. Hickman peel away catheter, followed by Jackman et al. [<xref rid="B18" ref-type="bibr">18</xref>] in 1998 utilizing an 11 Fr. peel-away access sheath, with comparable to standard PCNL results. The first description of standard &#x0201c;minimally invasive PCNL&#x0201d; with specialized 12-Fr rigid nephroscope and 15-Fr access sheath came out in 2001. However, according to the authors' note, despite the fact that no hemorrhage has occurred in a group of 19 patients, miniaturized instruments were associated with significant operative time increase with larger stone masses [<xref rid="B19" ref-type="bibr">19</xref>], due to the fact that utilization of a smaller sheaths are associated with more difficult stone fragment retrieval and need of additional tools such as disposable retrieval baskets [<xref rid="B4" ref-type="bibr">4</xref>]. It was not until Nagele et al. [<xref rid="B3" ref-type="bibr">3</xref>] in 2008 reported on a &#x0201c;Newly Designed Amplatz Sheath&#x0201d; (Karl Storz) with the vacuum cleaner effect, which was nicely depicted in a study by Nicklas et al. [<xref rid="B4" ref-type="bibr">4</xref>]. The basis of this effect lies in Bernoulli's principle, according to which an increase in the speed of a fluid in the constriction zone occurs simultaneously with a decrease in pressure [<xref rid="B20" ref-type="bibr">20</xref>], also known as &#x02018;pseudocavity&#x02019; which is being located at the tip of the nephroscope during mini-PCNL able to extract stone fragments through access sheath without any additional stone extracting devices [<xref rid="B4" ref-type="bibr">4</xref>]. Besides &#x02018;Bernoulli effect&#x02019; or &#x02018;Vacuum cleaner effect&#x02019; passive or active wash out as well as purging effect can also be utilized to gain maximum stonefree rate during mini-PCNL, though were not used in our study [<xref rid="B21" ref-type="bibr">21</xref>].</p><p>Several attempts have been made to compare mini-PCNL to standard PCNL. The former has been shown to be associated with reduced morbidity, pain and blood loss compared to standard PCNL [<xref rid="B22" ref-type="bibr">22</xref><xref rid="B23" ref-type="bibr">23</xref>]. In a series of more than 1,000 patients using a 16-Fr access sheath bleeding complications occurred in less than 1.5% [<xref rid="B24" ref-type="bibr">24</xref>]. For medium sized stones (1&#x02013;2 cm) no significant differences between mini- and standard PCNL regarding stone free and complication rates were observed. However hospital stay and Hb drop were less in the mini-PCNL group. The only parameter was in favor to standard PCNL - the operative time, which was 12&#x02013;14 minutes shorter in average [<xref rid="B14" ref-type="bibr">14</xref>]. Suggested in our study &#x02018;Bernoulli maneuver&#x02019; with its additional 12 minutes possibly could offset this time difference making mini-PCNL an attractive option for medium sized stones (1&#x02013;2 cm). One can raise a fair question, if SWL is not an option due to unfavorable stone factors [<xref rid="B25" ref-type="bibr">25</xref>], why not to use an endoscopic removal in medium-sized stones instead of mini-PCNL as existing guidelines dictate? [<xref rid="B6" ref-type="bibr">6</xref>]. The answer lies in residual fragments. As was nicely depicted even miniscule residuals &#x0003c;1 mm could affect an early recurrence, possibly to a delayed nidus effect [<xref rid="B26" ref-type="bibr">26</xref>]. Not speaking about time and expenditures needed to leave a patient absolutely stone-free with the endoscopic route.</p><p>Our study has limitations that should be mentioned. First, the study is a single-surgical-center study thus generalizability of this data is limited. Moreover during mini-PCNL in control group to render patient stone-free the sheath is often moved in all types of directions, which is also should be considered. Second, the study sample size is relatively low and larger studies are required. Finally, surgeon's subjective feeling was not measured and future studies with validated questionnaires would help to elucidate if the maneuver makes clinically significant difference to the surgeon during the procedure.</p></sec><sec sec-type="conclusions"><title>CONCLUSIONS</title><p>&#x02018;Bernoulli maneuver&#x02019; during the mini-PCNL significantly reduces the nephroscopy time without any compromise in stone-free and complication rates. Future multicenter studies with larger number of patients are required to confirm our findings.</p></sec></body><back><ack><title>ACKNOWLEDGMENTS</title><p>We would like to thank Dr. Nikita Khromov-Borisov for his assistance with statistical analysis.</p></ack><fn-group><fn fn-type="COI-statement"><p><bold>CONFLICTS OF INTEREST:</bold> The authors have nothing to disclose.</p></fn></fn-group><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernstr&#x000f6;m</surname><given-names>I</given-names></name><name><surname>Johansson</surname><given-names>B</given-names></name></person-group><article-title>Percutaneous pyelolithotomy: a new extraction technique</article-title><source>Scand J Urol Nephrol</source><year>1976</year><volume>10</volume><fpage>257</fpage><lpage>259</lpage><pub-id pub-id-type="pmid">1006190</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helal</surname><given-names>M</given-names></name><name><surname>Black</surname><given-names>T</given-names></name><name><surname>Lockhart</surname><given-names>J</given-names></name><name><surname>Figueroa</surname><given-names>TE</given-names></name></person-group><article-title>The Hickman peel-away sheath: alternative for pediatric percutaneous nephrolithotomy</article-title><source>J Endourol</source><year>1997</year><volume>11</volume><fpage>171</fpage><lpage>172</lpage><pub-id pub-id-type="pmid">9181444</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagele</surname><given-names>U</given-names></name><name><surname>Horstmann</surname><given-names>M</given-names></name><name><surname>Sievert</surname><given-names>KD</given-names></name><name><surname>Kuczyk</surname><given-names>MA</given-names></name><name><surname>Walcher</surname><given-names>U</given-names></name><name><surname>Hennenlotter</surname><given-names>J</given-names></name><etal/></person-group><article-title>A newly designed amplatz sheath decreases intrapelvic irrigation pressure during mini-percutaneous nephrolitholapaxy: an in-vitro pressure-measurement and microscopic study</article-title><source>J Endourol</source><year>2007</year><volume>21</volume><fpage>1113</fpage><lpage>1116</lpage><pub-id pub-id-type="pmid">17941796</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicklas</surname><given-names>AP</given-names></name><name><surname>Schilling</surname><given-names>D</given-names></name><name><surname>Bader</surname><given-names>MJ</given-names></name><name><surname>Herrmann</surname><given-names>TR</given-names></name><name><surname>Nagele</surname><given-names>U</given-names></name></person-group><collab>Training and Research in Urological Surgery and Technology (T.R.U.S.T.)-Group</collab><article-title>The vacuum cleaner effect in minimally invasive percutaneous nephrolitholapaxy</article-title><source>World J Urol</source><year>2015</year><volume>33</volume><fpage>1847</fpage><lpage>1853</lpage><pub-id pub-id-type="pmid">25833660</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eastwell</surname><given-names>PH</given-names></name></person-group><article-title>Bernoulli? Perhaps, but what about viscosity?</article-title><source>Sci Educ Rev</source><year>2007</year><volume>6</volume><fpage>1</fpage><lpage>13</lpage></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>T&#x000fc;rk</surname><given-names>C</given-names></name><name><surname>Pet&#x00159;&#x000ed;k</surname><given-names>A</given-names></name><name><surname>Sarica</surname><given-names>K</given-names></name><name><surname>Seitz</surname><given-names>C</given-names></name><name><surname>Skolarikos</surname><given-names>A</given-names></name><name><surname>Straub</surname><given-names>M</given-names></name><etal/></person-group><article-title>EAU guidelines on interventional treatment for urolithiasis</article-title><source>Eur Urol</source><year>2016</year><volume>69</volume><fpage>475</fpage><lpage>482</lpage><pub-id pub-id-type="pmid">26344917</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>S</given-names></name><name><surname>Jagtap</surname><given-names>J</given-names></name><name><surname>Sabnis</surname><given-names>RB</given-names></name><name><surname>Desai</surname><given-names>MR</given-names></name></person-group><article-title>Training in percutaneous nephrolithotomy</article-title><source>Curr Opin Urol</source><year>2013</year><volume>23</volume><fpage>147</fpage><lpage>151</lpage><pub-id pub-id-type="pmid">23357932</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gadzhiev</surname><given-names>N</given-names></name><name><surname>Brovkin</surname><given-names>S</given-names></name><name><surname>Grigoryev</surname><given-names>V</given-names></name><name><surname>Tagirov</surname><given-names>N</given-names></name><name><surname>Korol</surname><given-names>V</given-names></name><name><surname>Petrov</surname><given-names>S</given-names></name></person-group><article-title>Sculpturing in urology, or how to make percutaneous nephrolithotomy easier</article-title><source>J Endourol</source><year>2015</year><volume>29</volume><fpage>512</fpage><lpage>517</lpage><pub-id pub-id-type="pmid">25321395</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raman</surname><given-names>JD</given-names></name><name><surname>Bagrodia</surname><given-names>A</given-names></name><name><surname>Gupta</surname><given-names>A</given-names></name><name><surname>Bensalah</surname><given-names>K</given-names></name><name><surname>Cadeddu</surname><given-names>JA</given-names></name><name><surname>Lotan</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Natural history of residual fragments following percutaneous nephrostolithotomy</article-title><source>J Urol</source><year>2009</year><volume>181</volume><fpage>1163</fpage><lpage>1168</lpage><pub-id pub-id-type="pmid">19152935</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammer</surname><given-names>&#x000d8;</given-names></name><name><surname>Harper</surname><given-names>DA</given-names></name><name><surname>Ryan</surname><given-names>PD</given-names></name></person-group><article-title>PAST: paleontological statistics software package for education and data analysis</article-title><source>Palaeontol Electron</source><year>2001</year><volume>4</volume><fpage>9</fpage><lpage>18</lpage></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faul</surname><given-names>F</given-names></name><name><surname>Erdfelder</surname><given-names>E</given-names></name><name><surname>Lang</surname><given-names>AG</given-names></name><name><surname>Buchner</surname><given-names>A</given-names></name></person-group><article-title>G<sup>*</sup>Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences</article-title><source>Behav Res Methods</source><year>2007</year><volume>39</volume><fpage>175</fpage><lpage>191</lpage><pub-id pub-id-type="pmid">17695343</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>P</given-names></name><name><surname>Bach</surname><given-names>C</given-names></name><name><surname>Kachrilas</surname><given-names>S</given-names></name><name><surname>Papatsoris</surname><given-names>AG</given-names></name><name><surname>Buchholz</surname><given-names>N</given-names></name><name><surname>Masood</surname><given-names>J</given-names></name></person-group><article-title>Supine percutaneous nephrolithotomy (PCNL): &#x02018;in vogue&#x02019; but in which position?</article-title><source>BJU Int</source><year>2012</year><volume>110</volume><issue>11 Pt C</issue><fpage>E1018</fpage><lpage>E1021</lpage><pub-id pub-id-type="pmid">22564784</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganpule</surname><given-names>AP</given-names></name><name><surname>Bhattu</surname><given-names>AS</given-names></name><name><surname>Desai</surname><given-names>M</given-names></name></person-group><article-title>PCNL in the twenty-first century: role of Microperc, Miniperc, and Ultraminiperc</article-title><source>World J Urol</source><year>2015</year><volume>33</volume><fpage>235</fpage><lpage>240</lpage><pub-id pub-id-type="pmid">25316173</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>S</given-names></name><name><surname>Sharma</surname><given-names>R</given-names></name><name><surname>Garg</surname><given-names>C</given-names></name><name><surname>Kurien</surname><given-names>A</given-names></name><name><surname>Sabnis</surname><given-names>R</given-names></name><name><surname>Desai</surname><given-names>M</given-names></name></person-group><article-title>Prospective comparative study of miniperc and standard PNL for treatment of 1 to 2 cm size renal stone</article-title><source>BJU Int</source><year>2011</year><volume>108</volume><fpage>896</fpage><lpage>899</lpage><pub-id pub-id-type="pmid">21477212</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wright</surname><given-names>A</given-names></name><name><surname>Rukin</surname><given-names>N</given-names></name><name><surname>Smith</surname><given-names>D</given-names></name><name><surname>De la Rosette</surname><given-names>J</given-names></name><name><surname>Somani</surname><given-names>BK</given-names></name></person-group><article-title>&#x02018;Mini, ultra, micro&#x02019; - nomenclature and cost of these new minimally invasive percutaneous nephrolithotomy (PCNL) techniques</article-title><source>Ther Adv Urol</source><year>2016</year><volume>8</volume><fpage>142</fpage><lpage>146</lpage><pub-id pub-id-type="pmid">27034726</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabnis</surname><given-names>RB</given-names></name><name><surname>Ganesamoni</surname><given-names>R</given-names></name><name><surname>Sarpal</surname><given-names>R</given-names></name></person-group><article-title>Miniperc: what is its current status?</article-title><source>Curr Opin Urol</source><year>2012</year><volume>22</volume><fpage>129</fpage><lpage>133</lpage><pub-id pub-id-type="pmid">22273758</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helal</surname><given-names>M</given-names></name><name><surname>Black</surname><given-names>T</given-names></name><name><surname>Lockhart</surname><given-names>J</given-names></name><name><surname>Figueroa</surname><given-names>TE</given-names></name></person-group><article-title>The Hickman peel-away sheath: alternative for pediatric percutaneous nephrolithotomy</article-title><source>J Endourol</source><year>1997</year><volume>11</volume><fpage>171</fpage><lpage>172</lpage><pub-id pub-id-type="pmid">9181444</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackman</surname><given-names>SV</given-names></name><name><surname>Hedican</surname><given-names>SP</given-names></name><name><surname>Peters</surname><given-names>CA</given-names></name><name><surname>Docimo</surname><given-names>SG</given-names></name></person-group><article-title>Percutaneous nephrolithotomy in infants and preschool age children: experience with a new technique</article-title><source>Urology</source><year>1998</year><volume>52</volume><fpage>697</fpage><lpage>701</lpage><pub-id pub-id-type="pmid">9763096</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lahme</surname><given-names>S</given-names></name><name><surname>Bichler</surname><given-names>KH</given-names></name><name><surname>Strohmaier</surname><given-names>WL</given-names></name><name><surname>G&#x000f6;tz</surname><given-names>T</given-names></name></person-group><article-title>Minimally invasive PCNL in patients with renal pelvic and calyceal stones</article-title><source>Eur Urol</source><year>2001</year><volume>40</volume><fpage>619</fpage><lpage>624</lpage><pub-id pub-id-type="pmid">11805407</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rassweiler</surname><given-names>J</given-names></name><name><surname>Rassweiler</surname><given-names>MC</given-names></name><name><surname>Klein</surname><given-names>J</given-names></name></person-group><article-title>New technology in ureteroscopy and percutaneous nephrolithotomy</article-title><source>Curr Opin Urol</source><year>2016</year><volume>26</volume><fpage>95</fpage><lpage>106</lpage><pub-id pub-id-type="pmid">26626887</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagele</surname><given-names>U</given-names></name><name><surname>Nicklas</surname><given-names>A</given-names></name></person-group><article-title>Vacuum cleaner effect, purging effect, active and passive wash out: a new terminology in hydrodynamic stone retrival is arising--Does it affect our endourologic routine?</article-title><source>World J Urol</source><year>2016</year><volume>34</volume><fpage>143</fpage><lpage>144</lpage><pub-id pub-id-type="pmid">26002252</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamaguchi</surname><given-names>A</given-names></name><name><surname>Skolarikos</surname><given-names>A</given-names></name><name><surname>Buchholz</surname><given-names>NP</given-names></name><name><surname>Chom&#x000f3;n</surname><given-names>GB</given-names></name><name><surname>Grasso</surname><given-names>M</given-names></name><name><surname>Saba</surname><given-names>P</given-names></name><etal/></person-group><article-title>Operating times and bleeding complications in percutaneous nephrolithotomy: a comparison of tract dilation methods in 5,537 patients in the Clinical Research Office of the Endourological Society Percutaneous Nephrolithotomy Global Study</article-title><source>J Endourol</source><year>2011</year><volume>25</volume><fpage>933</fpage><lpage>939</lpage><pub-id pub-id-type="pmid">21568697</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knoll</surname><given-names>T</given-names></name><name><surname>Wezel</surname><given-names>F</given-names></name><name><surname>Michel</surname><given-names>MS</given-names></name><name><surname>Honeck</surname><given-names>P</given-names></name><name><surname>Wendt-Nordahl</surname><given-names>G</given-names></name></person-group><article-title>Do patients benefit from miniaturized tubeless percutaneous nephrolithotomy? A comparative prospective study</article-title><source>J Endourol</source><year>2010</year><volume>24</volume><fpage>1075</fpage><lpage>1079</lpage><pub-id pub-id-type="pmid">20575685</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>G</given-names></name><name><surname>Guo</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Luo</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Lai</surname><given-names>P</given-names></name><etal/></person-group><article-title>A novel minimally invasive percutaneous nephrolithotomy technique: safety and efficacy report</article-title><source>Scand J Urol</source><year>2015</year><volume>49</volume><fpage>174</fpage><lpage>180</lpage><pub-id pub-id-type="pmid">25247463</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Nahas</surname><given-names>AR</given-names></name><name><surname>El-Assmy</surname><given-names>AM</given-names></name><name><surname>Mansour</surname><given-names>O</given-names></name><name><surname>Sheir</surname><given-names>KZ</given-names></name></person-group><article-title>A prospective multivariate analysis of factors predicting stone disintegration by extracorporeal shock wave lithotripsy: the value of high-resolution noncontrast computed tomography</article-title><source>Eur Urol</source><year>2007</year><volume>51</volume><fpage>1688</fpage><lpage>1693</lpage><pub-id pub-id-type="pmid">17161522</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hein</surname><given-names>S</given-names></name><name><surname>Miernik</surname><given-names>A</given-names></name><name><surname>Wilhelm</surname><given-names>K</given-names></name><name><surname>Schlager</surname><given-names>D</given-names></name><name><surname>Schoeb</surname><given-names>DS</given-names></name><name><surname>Adams</surname><given-names>F</given-names></name><etal/></person-group><article-title>Endoscopically determined stone clearance predicts disease recurrence within 5 years after retrograde intrarenal surgery</article-title><source>J Endourol</source><year>2016</year><volume>30</volume><fpage>644</fpage><lpage>649</lpage><pub-id pub-id-type="pmid">27021947</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" orientation="portrait" position="float"><label>Fig. 1</label><caption><title>Patient prone strapped to the operating table.</title></caption><graphic xlink:href="icu-58-179-g001"/></fig><fig id="F2" orientation="portrait" position="float"><label>Fig. 2</label><caption><title>Standard prone (A), tilted prone (B), and tilted prone (C) with hand assistance.</title></caption><graphic xlink:href="icu-58-179-g002"/></fig><fig id="F3" orientation="portrait" position="float"><label>Fig. 3</label><caption><title>Nephroscopy time in control (C) and Bernoulli (B) groups.</title></caption><graphic xlink:href="icu-58-179-g003"/></fig><fig id="F4" orientation="portrait" position="float"><label>Fig. 4</label><caption><title>Correlations between stone size and nephroscopy time (A) and between nephroscopy time and haemoglobin drop (B). 95% confidence ellipses are shown. r, linear Pearson correlation coefficient; rS, Spearman correlation coefficient.</title></caption><graphic xlink:href="icu-58-179-g004"/></fig><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><title>Relevant patient characteristics</title></caption><alternatives><graphic xlink:href="icu-58-179-i001"/><table frame="hsides" rules="rows"><col width="20%" span="1"/><col width="16%" span="1"/><col width="16%" span="1"/><col width="16%" span="1"/><col width="16%" span="1"/><col width="16%" span="1"/><thead><tr><th valign="middle" align="center" rowspan="2" colspan="1" style="background-color:rgb(217,220,235)">Characteristic</th><th valign="middle" align="center" rowspan="1" colspan="2" style="background-color:rgb(217,220,235)">Control group (n=40)</th><th valign="middle" align="center" rowspan="1" colspan="2" style="background-color:rgb(217,220,235)">Bernoulli group (n=27)</th><th valign="middle" align="center" rowspan="2" colspan="1" style="background-color:rgb(217,220,235)">p-value</th></tr><tr><th valign="middle" align="center" rowspan="1" colspan="1" style="background-color:rgb(217,220,235)">Median</th><th valign="middle" align="center" rowspan="1" colspan="1" style="background-color:rgb(217,220,235)">95% CL</th><th valign="middle" align="center" rowspan="1" colspan="1" style="background-color:rgb(217,220,235)">Median</th><th valign="middle" align="center" rowspan="1" colspan="1" style="background-color:rgb(217,220,235)">95% CL</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Age (y)</td><td valign="top" align="center" rowspan="1" colspan="1">52</td><td valign="top" align="center" rowspan="1" colspan="1">48, 55</td><td valign="top" align="center" rowspan="1" colspan="1">52</td><td valign="top" align="center" rowspan="1" colspan="1">47, 57</td><td valign="top" align="right" rowspan="1" colspan="1">0.97</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Sex (%)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="right" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Male</td><td valign="top" align="center" rowspan="1" colspan="1">60</td><td valign="top" align="center" rowspan="1" colspan="1">42, 76</td><td valign="top" align="center" rowspan="1" colspan="1">52</td><td valign="top" align="center" rowspan="1" colspan="1">30, 74</td><td valign="top" align="right" rowspan="1" colspan="1">0.62</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Female</td><td valign="top" align="center" rowspan="1" colspan="1">40</td><td valign="top" align="center" rowspan="1" colspan="1">24, 58</td><td valign="top" align="center" rowspan="1" colspan="1">48</td><td valign="top" align="center" rowspan="1" colspan="1">26, 70</td><td valign="top" align="right" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Location (%)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="right" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Calyx</td><td valign="top" align="center" rowspan="1" colspan="1">51</td><td valign="top" align="center" rowspan="1" colspan="1">33, 70</td><td valign="top" align="center" rowspan="1" colspan="1">56</td><td valign="top" align="center" rowspan="1" colspan="1">34, 75</td><td valign="top" align="right" rowspan="1" colspan="1">0.81</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Pelvis</td><td valign="top" align="center" rowspan="1" colspan="1">49</td><td valign="top" align="center" rowspan="1" colspan="1">31, 67</td><td valign="top" align="center" rowspan="1" colspan="1">44</td><td valign="top" align="center" rowspan="1" colspan="1">25, 66</td><td valign="top" align="right" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Stone size (max.) (mm)</td><td valign="top" align="center" rowspan="1" colspan="1">14</td><td valign="top" align="center" rowspan="1" colspan="1">13, 15</td><td valign="top" align="center" rowspan="1" colspan="1">13</td><td valign="top" align="center" rowspan="1" colspan="1">11, 14</td><td valign="top" align="right" rowspan="1" colspan="1">0.26</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Stone density (HU)</td><td valign="top" align="center" rowspan="1" colspan="1">1,260</td><td valign="top" align="center" rowspan="1" colspan="1">1,200, 1,320</td><td valign="top" align="center" rowspan="1" colspan="1">1,190</td><td valign="top" align="center" rowspan="1" colspan="1">1,130, 1,260</td><td valign="top" align="right" rowspan="1" colspan="1">0.12</td></tr></tbody></table></alternatives><table-wrap-foot><fn><p>CL, confidence limit; HU, Hounsfield units.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2</label><caption><title>Comprehensive data analysis (statistical descriptions, tests, effect size measures, power, and predictions) of nephroscopy time in both groups</title></caption><alternatives><graphic xlink:href="icu-58-179-i002"/><table frame="hsides" rules="rows"><col width="30%" span="1"/><col width="15%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="15%" span="1"/><thead><tr><th valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(217,220,235)">Parameter</th><th valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(217,220,235)">Mean</th><th valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(217,220,235)">Estimates with 95% CLs</th><th valign="top" align="left" rowspan="1" colspan="1" style="background-color:rgb(217,220,235)">95% prediction limits</th><th valign="top" align="center" rowspan="1" colspan="1" style="background-color:rgb(217,220,235)">p-value<sup>a</sup></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Control group (<italic>M</italic><sub>C</sub>)</td><td valign="top" align="center" rowspan="1" colspan="1">35</td><td valign="top" align="center" rowspan="1" colspan="1">32, 39</td><td valign="top" align="center" rowspan="1" colspan="1">12, 58</td><td valign="top" align="center" rowspan="1" colspan="1">0.33</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Bernoulli group (<italic>M</italic><sub>B</sub>)</td><td valign="top" align="center" rowspan="1" colspan="1">23</td><td valign="top" align="center" rowspan="1" colspan="1">19, 26</td><td valign="top" align="center" rowspan="1" colspan="1">4, 42</td><td valign="top" align="center" rowspan="1" colspan="1">6&#x02219;10<sup>&#x02212;5</sup></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Mean difference (<italic>M</italic><sub>C</sub>&#x02013;<italic>M</italic><sub>B</sub>)</td><td valign="top" align="center" rowspan="1" colspan="1">12</td><td valign="top" align="center" rowspan="1" colspan="1">8, 18</td><td valign="top" align="center" rowspan="1" colspan="1">5.3, 20</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Standardized Cohen effect size (<italic>d</italic><sub>st</sub>)</td><td valign="top" align="center" rowspan="1" colspan="1">1.2</td><td valign="top" align="center" rowspan="1" colspan="1">0.7, 1.8</td><td valign="top" align="center" rowspan="1" colspan="1">0.49, 2.0</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">p-value</td><td valign="top" align="center" rowspan="1" colspan="1">1.5&#x02219;10<sup>&#x02212;5</sup></td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">10<sup>&#x02212;11</sup>, 0.027</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Achieved power (<italic>Pow</italic>=1&#x02212;&#x003b2;)</td><td valign="top" align="center" rowspan="1" colspan="1">0.998</td><td valign="top" align="center" rowspan="1" colspan="1">0.77, 1.00</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Bayes factor (<italic>BF</italic><sub>10</sub>)</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">2,340</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn><p>CL, confidence limit; <italic>M</italic><sub>C</sub>, mean of group C; <italic>M</italic><sub>B</sub>, mean of group B.</p><p><sup>a</sup>:Shapiro-Wilk normality test.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T3" orientation="portrait" position="float"><label>Table 3</label><caption><title>Postoperative parameters</title></caption><alternatives><graphic xlink:href="icu-58-179-i003"/><table frame="hsides" rules="rows"><col width="30%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><thead><tr><th valign="middle" align="center" rowspan="2" colspan="1" style="background-color:rgb(217,220,235)">Parameter</th><th valign="middle" align="center" rowspan="1" colspan="2" style="background-color:rgb(217,220,235)">Control group</th><th valign="middle" align="center" rowspan="1" colspan="2" style="background-color:rgb(217,220,235)">Bernoulli group</th><th valign="middle" align="center" rowspan="2" colspan="1" style="background-color:rgb(217,220,235)">p-value</th></tr><tr><th valign="middle" align="center" rowspan="1" colspan="1" style="background-color:rgb(217,220,235)">Median</th><th valign="middle" align="center" rowspan="1" colspan="1" style="background-color:rgb(217,220,235)">95% CL</th><th valign="middle" align="center" rowspan="1" colspan="1" style="background-color:rgb(217,220,235)">Median</th><th valign="middle" align="center" rowspan="1" colspan="1" style="background-color:rgb(217,220,235)">95% CL</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">White blood cell (/mm<sup>3</sup>)</td><td valign="top" align="center" rowspan="1" colspan="1">10,600</td><td valign="top" align="center" rowspan="1" colspan="1">9,900, 11,300</td><td valign="top" align="center" rowspan="1" colspan="1">11,100</td><td valign="top" align="center" rowspan="1" colspan="1">10,200, 12,000</td><td valign="top" align="left" rowspan="1" colspan="1">0.36</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Hemoglobin drop (g/dL)</td><td valign="top" align="center" rowspan="1" colspan="1">1.5</td><td valign="top" align="center" rowspan="1" colspan="1">1.3, 1.6</td><td valign="top" align="center" rowspan="1" colspan="1">1.1</td><td valign="top" align="center" rowspan="1" colspan="1">1.0, 1.3</td><td valign="top" align="left" rowspan="1" colspan="1">0.006</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Creatinine (mg/dL)</td><td valign="top" align="center" rowspan="1" colspan="1">0.97</td><td valign="top" align="center" rowspan="1" colspan="1">0.86, 1.07</td><td valign="top" align="center" rowspan="1" colspan="1">0.93</td><td valign="top" align="center" rowspan="1" colspan="1">0.83, 1.03</td><td valign="top" align="left" rowspan="1" colspan="1">0.63</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Stone free status defined by CT (%)</td><td valign="top" align="center" rowspan="1" colspan="1">88</td><td valign="top" align="center" rowspan="1" colspan="1">73, 96</td><td valign="top" align="center" rowspan="1" colspan="1">89</td><td valign="top" align="center" rowspan="1" colspan="1">69, 97</td><td valign="top" align="left" rowspan="1" colspan="1">1.0</td></tr></tbody></table></alternatives><table-wrap-foot><fn><p>CL, confidence limit.</p></fn></table-wrap-foot></table-wrap></floats-group></article>